logo

Nippon India Nifty Pharma ETF

Category: ETFs Launch Date: 05-07-2021
AUM:

₹ 980.55 Cr

Expense Ratio

0.21%

Benchmark

NIFTY Pharma TRI

ISIN

INF204KC1089

Minimum Investment

1000.0

Minimum Topup

0.0

Minimum SIP Amount

100

Fund Manager

Jitendra Tolani

Fund Performance 1Y (%) 3Y (%) 5Y (%)
Nippon India Nifty Pharma ETF 1.61 20.6 -
Nifty Pharma TRI 1.87 20.92 15.42
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
22.5498
Last change
-0.78 (-3.4417%)
Fund Size (AUM)
₹ 980.55 Cr
Performance
11.62% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Manager
Jitendra Tolani
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- 22.82
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- 10.92
CIPLA LIMITED EQ NEW FV RS.2/- 10.7
Dr. Reddys Laboratories Ltd 9.87
LUPIN LIMITED EQ NEW F.V. RS.2/- 5.92
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- 4.5
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- 4.01
LAURUS LABS LIMITED EQ NEW FV RS. 2/- 3.58
ALKEM LABORATORIES LIMITED EQ 3.36
GLENMARK PHARMACEUTICALS LIMITED EQ NEW FV RE.1/- 3.34

Sector Allocation

Sector Holdings (%)
Healthcare 99.83